SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
vaccines
An SI Board Since August 2000
Posts SubjectMarks Bans
26 10 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
There are continuously new developments in this field.

The objective of this thread is to collect a sample of interesting developments and companies in this field under this heading..

martin
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
26Unless you're Vaxgen. <g>nigel bates-11/11/2004
25Signals looks at the less than favorable risk/reward for developers of vaccines:tuck-11/11/2004
24[Totally synthetic vaccine targeting epithelial tumors ] >>Published onlituck-7/27/2004
23Well, there are 11 bookmarks... Should be a more active thread, but a lot of renigel bates-3/10/2004
22>>Immune system versus tumor: shifting the balance in favor of DCs and efftuck-3/10/2004
21Signals looks at vaccines against STDs. signalsmag.com Cheers, Tucktuck-7/21/2003
20Vical to Manufacture West Nile Virus Vaccine Tuesday, July 15, 2003 00:00 AM EA.J. Mullen-7/15/2003
19CELL down in AHayn rand-5/1/2003
18Epimmune and Merck Enter Into Agreement SAN DIEGO, May 1 /PRNewswire-FirstCall/nigel bates-5/1/2003
17Oxxon Pharmaccines™ Raises £15 Million in International Funding Round Fundsnigel bates-5/1/2003
16WHITEHOUSE STATION, N.J. -- Merck & Co. plans to file five products currentlnigel bates-12/10/2002
15BRISBANE, Calif., Oct. 21 /PRNewswire-FirstCall/ -- The independent board that onigel bates-10/21/2002
14BERKELEY, Calif., Sept. 4 /PRNewswire/ -- Dynavax Technologies, a privately heldnigel bates-9/4/2002
13Fri May 10, 5:35 PM ET By Hannah Cleaver BERLIN (Reuters Health) - German sciennigel bates-5/11/2002
12Cambridge, UK - 14 February 2002 - Acambis plc ("Acambis") (LSE: ACM, nigel bates-2/14/2002
11Epimmune and Genencor Announce The Achievement of Pre-Clinical Milestone From Thnigel bates-1/15/2002
10Plants as sources of vaccines. Thumbnail. Transgenic Plants for Vaccine Productkeokalani'nui-10/12/2001
9Thanks, Wilder. You're just way ahead of me today. <g> nignigel bates-10/11/2001
8MAXY. New Adjuvant and Cancer Vaccines. snip Therapeutic Cancer Vaccine keokalani'nui-10/11/2001
76 April 2001 – Acambis plc (“Acambis”) (LSE: ACM, NASDAQ: ACAM) is to present denigel bates-4/6/2001
6KEYSTONE, Colo., April 2 /PRNewswire/ -- Vical Incorporated (Nasdaq: VICL - newsnigel bates-4/3/2001
5April 3 /PRNewswire/ -- Crucell N.V. (Nasdaq: CRXL, EAX Amsterdam: CRXL), a leadnigel bates-4/3/2001
4KEYSTONE, Colo., April 2 /PRNewswire/ -- Epimmune Inc. (Nasdaq: EPMN - news) todnigel bates-4/2/2001
3SAN DIEGO, March 27 /PRNewswire/ -- Epimmune Inc. (Nasdaq: EPMN - news) announcenigel bates-3/27/2001
2Eat Your Medicine! Vaccine Developers Chase a Field of Dreams ArticleDoubleTwiJongmans-8/20/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News